<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000044880">
  <TermName>10-propargyl-10-deazaaminopterin</TermName>
  <TermPronunciation>(10-proh-PAR-jil-10-dee-AY-zuh-a-mih-NOP-teh-rin)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called folate analogs.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000728188" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;10-propargyl-10-deazaaminopterin&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000728189" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;10-propargil-10-deazaaminopterina&quot;" language="es" id="_4"/>
  <SpanishTermName>10-propargil-10-deazaaminopterina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un análogo del folato.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2003-10-15</DateLastModified>
</GlossaryTerm>
